Mo Yueting, He Xiyuan, Shi Peixin, Ning Yifei, Zhou Mingmei, Cui Hao, Zhang Ting
Institute for Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Front Immunol. 2025 Jun 12;16:1561477. doi: 10.3389/fimmu.2025.1561477. eCollection 2025.
INTRODUCTION: Fufang E'jiao Jiang has been extensively utilized to replenish qi and nourish blood as the homology of medicine and food. METHODS: We analyzed the effects of FEJ on cyclophosphamide and acetylphenylhydrazine-induced anemia mice through gut microbiome analysis, fecal metabolomics, and transcriptome sequencing. RESULTS: FEJ markedly alleviated the anemia symptoms in the mice. FEJ markedly alleviated the anemia symptoms caused by cyclophosphamide and acetylphenylhydrazine induction. FEJ improved the gut microbiome imbalance by inhibiting the proliferation of harmful bacteria and . Fecal metabolomic data showed that FEJ regulated metabolic disorders in anemia mice and was probably associated with L-leucine, L-proline, glycine, phenylalanine, propanoic acid and butanoic acid. Transcriptome analysis indicated the amelioration of anemia was predominantly associated with the hematopoietic cell lineage, osteoclast formation and B cell receptor signaling pathway. According to Spearman's correlation analysis, there was a strong link between gut microbiota and hematopoietic index, metabolites and genes. DISCUSSION: Our study supports the application of FEJ in anemia treatment.
引言:复方阿胶浆作为药食同源的产品,已被广泛用于补气养血。 方法:我们通过肠道微生物组分析、粪便代谢组学和转录组测序,分析了复方阿胶浆对环磷酰胺和乙酰苯肼诱导的贫血小鼠的影响。 结果:复方阿胶浆显著减轻了小鼠的贫血症状。复方阿胶浆显著减轻了环磷酰胺和乙酰苯肼诱导引起的贫血症状。复方阿胶浆通过抑制有害细菌的增殖改善了肠道微生物组失衡。粪便代谢组学数据表明,复方阿胶浆调节了贫血小鼠的代谢紊乱,可能与L-亮氨酸、L-脯氨酸、甘氨酸、苯丙氨酸、丙酸和丁酸有关。转录组分析表明,贫血的改善主要与造血细胞谱系、破骨细胞形成和B细胞受体信号通路有关。根据Spearman相关性分析,肠道微生物群与造血指标、代谢物和基因之间存在密切联系。 讨论:我们的研究支持复方阿胶浆在贫血治疗中的应用。
Cochrane Database Syst Rev. 2016-2-4
J Ethnopharmacol. 2024-10-5
Front Pharmacol. 2024-3-8
Aging (Albany NY). 2024-1-3